// Biotech and Pharma Therapeutics RSV vaccines may raise risk of Guillain-Barré syndrome, FDA preliminary analysis finds March 4, 2024 / RSV / Pfizer / GSK / Arexvy After decades of research into respiratory syncytial virus (RSV), Pfizer and GSK’s...

// Biotech and Pharma Therapeutics Boehringer Ingelheim’s Liver Drug Data Position It for MASH Clash With Eli Lilly February 26, 2024 / Boehringer Ingelheim / Liver / New Drug / MASH / Eli Lilly Preliminary Phase 2 results show 83%...